Important Note: Redirection of Services to ChiCTR
We would like to inform you that the Clinical Trial Registry page will discontinue the function of updating trial information directly on this platform. However, you will still be able to view the existing registration details. For any updates to trial information, you can use the China Clinical Trial Registry (ChiCTR) directly at https://www.chictr.org.cn. This change will be fully implemented by 2024-Aug-05. Thank you for your attention.
CUHK_CCT00277
2010-12-21
Prospective
Nil
Departmental Fund
Department of Paediatrics, CUHK
N/A
Dr. Albert Martin Li
Department of Paediatrics, 6/F, Clinical Sciences Building, Prince of Wales Hospital, Shatin, N.T.
2632 2855
albertmli@cuhk.edu.hk
Department of Paediatrics, Falculty of Medicine, The Chinese University of Hong Kong
Mr. Au Chun Ting
Department of Paediatrics, 6/F, Clinical Sciences Building, Prince of Wales Hospital, Shatin, N.T.
2632 2917
junau@cuhk.edu.hk
Department of Paediatrics, Falculty of Medicine, The Chinese University of Hong Kong
Effect of adenotonsillectomy on behavioural problems in children with mild obstructive sleep apnoea: a randomized controlled trial
Effect of adenotonsillectomy on behavioural problems in children with mild obstructive sleep apnoea: a randomized controlled trial
Effect of T&A on behavioural problems in children with OSA: a RCT
Hong Kong
Yes
2011-12-09
Childhood obstructive sleep apnoea
Procedure
Adenotonsillectomy
Subjects will have repeated assessment 6 months after adenotonsillectomy
Parents in this group will be given instructions to allow close monitoring of their child for any disease deterioration as reflected by worsening of symptoms such as loud snoring, allergic rhinitis symptoms, daytime sleepiness, inattention and hyperactivity problems, recurrent tonsillitis or other upper airway infections. They will also be provided with direct contact of the research team, and an earlier appointment for follow-up will be scheduled if necessary.
(i) Hong Kong Chinese prepubertal children aged between 6-11 years.
(ii) Mild OSA confirmed by nocturnal PSG (obstructive apnoea hypopnoea index (OAHI) between 1 and 5) and parental report of habitual snoring (at least 3 nights per week).
(iii) Tonsil size grading ≥1.
(iv) Written informed consent obtained from parents.
(i) Previous upper airway surgery.
(ii) Diagnosed to have attention deficit hyperactivity disorder (ADHD) or other psychiatric behavioural problems.
(iii) Craniofacial anomalies.
(iv) Severe health problems that could be exacerbated by delayed treatment of OSA.
(v) SpO2 nadir <90% in nocturnal PSG.
(vi) Receiving any forms of treatment for OSA.
(vii) Receiving any medications for allergic rhinitis including nasal corticosteroids and antihistamines within 6 weeks from baseline PSG.
(viii) Parental report that child has reached menarche (female participants).
(ix) Refusal of the surgical procedures.
6 years old
11 years old
Both Male and Female
Interventional
Randomized
Active
Single-blind
Parallel
2010-12-28
100
Unknown
Behavioural and psychosocial changes, assessed by Child Behavior Checklist (CBCL) at 6 months.
(i) Polysomnographic data at 6 months.
(ii) 24-hr blood pressure at 6 months.
(iii) Attention, assessed by Conners’ Continuous Performance Test II (CPT-II) at 6 months .
(iv) Symptoms of attention deficiency / hyperactivity disorder (ADHD) assessed by ADHD rating scale-IV parents version (investigator administered) at 6 months.
(v) Daytime sleepiness assessed by the modified Epworth Sleepiness Scale (ESS) at 6 months.
(vi) Fasting insulin and glucose, serum lipid profile and serum inflammatory marker; high sensitive CRP (hs-CRP) at 6 months.
2019-09-06
ChiCTR-TRC-10001136
2011-01-01
Yes
n/a
|
|
|
|
|
---|---|---|---|---|
No documents yet. |